Open AccessTreatment with Brivanib alaninate as a second-line monotherapy after Sorafenib failure in hepatocellular carcinoma
Author(s) -
Hong Zhu,
Chunyan Zhang,
Xi Yang,
Cheng Yi
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000014823
Subject(s) - medicine , sorafenib , hepatocellular carcinoma , oncology , lymph node , lung , carcinoma , lung cancer , gastroenterology , surgery